PKC plays a dual role in cancer development, acting as both a tumor promoter and tumor suppressor depending on the cellular context and the specific isoform involved. Aberrations in PKC signaling pathways can lead to uncontrolled cell proliferation, resistance to apoptosis, and enhanced metastatic potential, contributing to oncogenesis.
